Our Mission: empower the next generation of biotech leaders
For years, early-career scientists have struggled to access the mentorship, networks, and community needed to transform bold ideas into real-world impact.
Nucleate was created to ensure they never have to face that journey alone — and to provide the kind of support so many of us wish we had earlier in our own careers.
Our Challenge: leave the ladder down for the next generation of innovators during these uncertain times
To remain mission-aligned, independent, & accessible for the next 20 years, Nucleate needs a stable philanthropic foundation — built by the people who know us best: our mentors, advisors, and industry supporters.
Introducing Nucleate’s Leadership Council
A Leadership Community Shaping the Future of Nucleate
Members join a curated group of life science leaders and disruptors committed to leaving the ladder down for the next generation.
Membership Includes
Annual virtual “State of Nucleate” council meeting to help shape our organization’s future
Early exposure to standout innovation and talent across our global community
Preferred access to Nucleate events, including complimentary Summit registration
Recognition as a champion of the next generation on our website, impact report, and digital LinkedIn badge
The Leadership Council will play a critical role in sustaining the financial stability of Nucleate. We ask that you support this cause by donating $5,000 each year, or more if you can, to Nucleate as an expectation of being a member of the Leadership Council. Donations can be made anytime during the calendar year. As a 501(c)3 non-profit, your donation to Nucleate is tax deductible.
GREG ERMAN, Chairman NLC President & CEO Luzatu TherapeuticsMandi Williams Contract Specialist WashU St. LouisAnn DeWitt General Partner Engine VenturesAdam Jenkins Regional Director BioLabsJulien Pham Founder & Managing Partner Third Culture CapitalVas Bailey General Partner AnomalyBrock Reeve CEO Eos BioInnovationTere Williams CEO DUB TherapeuticsJosie Kishi Co-Founder Digital BiologyCheri Ackerman Araromi CEO Concerto BiosciencesLida Kourita Physician Gladstone InstitutesJeffrey Koury President ResearchHub FoundationSarah Cork Managing Partner Cork Maloney LLP Ben Kromnick General Manager RhoChris Garabedian CEO XontogenySamuel Kessel Senior Associate Locust WalkReginald Swift Founder & CEO Rubix LSLeonard Smith Tax Partner WithumDan Goddard Director CFGOSheila Gujrathi Managing Director SilverArc capitalFrancesca Devine Co-Founder, Managing Partner Devine Insights GroupJohn Cumbers Founder & CEO SynBioBetaLou Lieto Partner Wilson SonsiniPeter Barrett Partner Atlas VentureMichal Preminger CEO BioMed X Venture LabsChandra Ramanathan Board Chair NucleateJo Viney Cofounder, President & CEO Seismic TherapeuticLara Zibners Co-founder, Chair Calla Lily Clinical CareWarren Browne Partner Citrin Cooperman
Michael Gibson General Partner, Co-founder, 1517 FundMuhammet Tanc Co-founder & CEO, Nuclide Therapeutics
Join the Council
We invite you to become a founding member of the leadership council.
“Participating in Nucleate was critical in helping us prioritize our efforts and forge a path to get the company started. I don’t think we would have been as successful without the resources provided by the accelerator program and the people who helped along the way.”
– IVANA VASIC CEO, VITRA LABS
“Nucleate was so transformational—it changed my life, my career choices, and how I think about problem-solving and scaling organizations. You just don’t get this kind of experience in grad school.”
– MICHAEL RETCHIN FORMER CO-PRESIDENT, NUCLEATE CEO, SCALE MEDICINE
“We can’t lead in biotech if we cut the legs out from under early-stage innovation. Programs like Nucleate are important — they keep the pipeline alive by empowering young scientists to turn bold ideas into real breakthroughs.
That’s the kind of future we should be investing in.”
– CONGRESSMAN JAKE AUCHINCLOSS MASSACHUSETTS, FOURTH DISTRICT
Build the future of biotech with us.
Your Support Matters
Your support is a direct investment in the discoveries, therapies, and companies that will shape humanity’s future.
